Role of Myc in hepatocellular proliferation and hepatocarcinogenesis

Journal of Hepatology

Volumn 60, Issue 2, 2014, Pages 331-338

  Qu, Aijuan ^a   Jiang, Changtao ^a   Cai, Yan ^a   Kim, Jung Hwan ^a   Tanaka, Naoki ^a   Ward, Jerrold M ^b   Shah, Yatrik M ^a,c   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Global VetPathology   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

BrdU; Cell cycle control; Cell proliferation; Myc; Tumorigenesis

Indexed keywords

DIETHYLNITROSAMINE; FATTY ACID; MYC PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; SERUM ALBUMIN; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA REPLICATION; FATTY ACID OXIDATION; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE DISRUPTION; GENE EXPRESSION; GENETIC MODEL; HEPATOMEGALY; LIVER CARCINOGENESIS; LIVER CELL; MICROARRAY ANALYSIS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

ACOX1; ACYL-COA OXIDASE; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER; BHLH; BRDU; BROMODEOXYURIDINE; CDK; CELL CYCLE CONTROL; CELL PROLIFERATION; CHECKPOINT KINASE 1 HOMOLOGUE; CHEK1; CRE RECOMBINASE, TAMOXIFEN-INDUCIBLE ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN FUSION PROTEIN; CRE-ER(T2); CYCLIN-DEPENDENT KINASE; CYP4A10 AND CYP4A14; CYTOCHROMES P450 4A10 AND 4A14; DEN; DIETHYNITROSAMINE; FLOXED MYC ALLELE; INDUCIBLE LIVER-SPECIFIC MYC KNOCKOUT MOUSE; MCM; MINICHROMOSOME MAINTENANCE; MYC; MYC(FL/FL); MYC(FL/FL)MX-CRE; MYC(FL/FL,ERT2-CRE); PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Α; PPARΑ; RAD51; RAD51 HOMOLOG (S. CEREVISIAE); SA; SERUM ALBUMIN PROMOTER; TUMORIGENESIS; Α/Β INTERFERON-INDUCIBLE MX-PROMOTER DRIVING CRE RECOMBINASE;

ANIMALS; CELL PROLIFERATION; FATTY ACIDS; GENE KNOCKOUT TECHNIQUES; GENES, MYC; HEPATOCYTES; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, KNOCKOUT; MICRORNAS; MODELS, GENETIC; PPAR ALPHA; PYRIMIDINES; RNA, MESSENGER;

EID: 84892553819     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.09.024     Document Type: Article

References (41)

1. K. Kelly, B.H. Cochran, C.D. Stiles, and P. Leder Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor Cell 35 1983 603 610
2. C. Grandori, S.M. Cowley, L.P. James, and R.N. Eisenman The Myc/Max/Mad network and the transcriptional control of cell behavior Annu Rev Cell Dev Biol 16 2000 653 699
3. P. Yaswen, M. Goyette, P.R. Shank, and N. Fausto Expression of c-Ki-ras, c-Ha-ras, and c-myc in specific cell types during hepatocarcinogenesis Mol cell Biol 5 1985 780 786
4. A.J. Obaya, M.K. Mateyak, and J.M. Sedivy Mysterious liaisons: the relationship between c-Myc and the cell cycle Oncogene 18 1999 2934 2941
5. J.M. Peters, R.C. Cattley, and F.J. Gonzalez Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643 Carcinogenesis 18 1997 2029 2033
6. Y.M. Shah, K. Morimura, Q. Yang, T. Tanabe, M. Takagi, and F.J. Gonzalez Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation Mol Cell Biol 27 2007 4238 4247
7. M. Eilers, and R.N. Eisenman Myc's broad reach Genes Dev 22 2008 2755 2766
8. N. Meyer, and L.Z. Penn Reflecting on 25 years with Myc Nat Rev Cancer 8 2008 976 990
9. C.V. Dang, A. Le, and P. Gao Myc-induced cancer cell energy metabolism and therapeutic opportunities Clin Cancer Res 15 2009 6479 6483
10. H. Murakami, N.D. Sanderson, P. Nagy, P.A. Marino, G. Merlino, and S.S. Thorgeirsson Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis Cancer Res 53 1993 1719 1723
11. C.M. Shachaf, A.M. Kopelman, C. Arvanitis, A. Karlsson, S. Beer, and S. Mandl et al. Myc inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer Nature 431 2004 1112 1117
12. S. Hu, A. Balakrishnan, R.A. Bok, B. Anderton, P.E. Larson, and S.J. Nelson et al. 13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression Cell Metab 14 2011 131 142
13. M. Schuler, A. Dierich, P. Chambon, and D. Metzger Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse Genesis 39 2004 167 172
14. I.M. de Alboran, R.C. O'Hagan, F. Gartner, B. Malynn, L. Davidson, and R. Rickert et al. Analysis of C-Myc function in normal cells via conditional gene-targeted mutation Immunity 14 2001 45 55
15. A. Qu, M. Taylor, X. Xue, T. Matsubara, D. Metzger, and P. Chambon et al. Hypoxia-inducible transcription factor 2alpha promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis Hepatology 54 2011 472 483
16. S.D. Vesselinovitch, and N. Mihailovich Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse Cancer Res 43 1983 4253 4259
17. A. Qu, Y.M. Shah, T. Matsubara, Q. Yang, and F.J. Gonzalez PPARalpha-dependent activation of cell cycle control and DNA repair genes in hepatic nonparenchymal cells Toxicol Sci 118 2010 404 410
18. F.J. Gonzalez, and Y.M. Shah PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators Toxicology 246 2008 2 8
19. T.C. Chang, D. Yu, Y.S. Lee, E.A. Wentzel, D.E. Arking, and K.M. West et al. Widespread microRNA repression by Myc contributes to tumorigenesis Nat Genet 40 2008 43 50
20. S. Cairo, Y. Wang, A. de Reynies, K. Duroure, J. Dahan, and M.J. Redon et al. Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer Proc Natl Acad Sci U S A 107 2010 20471 20476
21. A.C. Davis, M. Wims, G.D. Spotts, S.R. Hann, and A. Bradley A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice Genes Dev 7 1993 671 682
22. J.A. Sanders, C. Schorl, A. Patel, J.M. Sedivy, and P.A. Gruppuso Postnatal liver growth and regeneration are independent of c-myc in a mouse model of conditional hepatic c-myc deletion BMC Physiol 12 2012 1
23. E. Baena, A. Gandarillas, M. Vallespinos, J. Zanet, O. Bachs, and C. Redondo et al. C-Myc regulates cell size and ploidy but is not essential for postnatal proliferation in liver Proc Natl Acad Sci U S A 102 2005 7286 7291
24. C. Postic, M. Shiota, K.D. Niswender, T.L. Jetton, Y. Chen, and J.M. Moates et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase J Biol Chem 274 1999 305 315
25. S. Yakar, J.L. Liu, B. Stannard, A. Butler, D. Accili, and B. Sauer et al. Normal growth and development in the absence of hepatic insulin-like growth factor I Proc Natl Acad Sci U S A 96 1999 7324 7329
26. D. Berkowitz Drug treatment of hyperlipidemia Mod Treat 6 1969 1341 1351
27. I. Issemann, and S. Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 347 1990 645 650
28. B. Staels, and J.C. Fruchart Therapeutic roles of peroxisome proliferator-activated receptor agonists Diabetes 54 2005 2460 2470
29. S.S. Lee, T. Pineau, J. Drago, E.J. Lee, J.W. Owens, and D.L. Kroetz et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators Mol Cell Biol 15 1995 3012 3022
30. J.K. Reddy, J.R. Warren, M.K. Reddy, and N.D. Lalwani Hepatic and renal effects of peroxisome proliferators: biological implications Ann N Y Acad Sci 386 1982 81 110
31. A. Koppen, R. Ait-Aissa, J. Koster, P.G. van Sluis, I. Ora, and H.N. Caron et al. Direct regulation of the minichromosome maintenance complex by MycN in neuroblastoma Eur J Cancer 43 2007 2413 2422
32. Z. Lygerou, and P. Nurse Cell cycle. License withheld-geminin blocks DNA replication Science 290 2000 2271 2273
33. K. Labib, J.A. Tercero, and J.F. Diffley Uninterrupted MCM2-7 function required for DNA replication fork progression Science 288 2000 1643 1647
34. D.I. Lin, P. Aggarwal, and J.A. Diehl Phosphorylation of MCM3 on Ser-112 regulates its incorporation into the MCM2-7 complex Proc Natl Acad Sci U S A 105 2008 8079 8084
35. Q. Liu, S. Guntuku, X.S. Cui, S. Matsuoka, D. Cortez, and K. Tamai et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint Genes Dev 14 2000 1448 1459
36. A. Hoglund, L.M. Nilsson, S.V. Muralidharan, L.A. Hasvold, P. Merta, and M. Rudelius et al. Therapeutic implications for the induced levels of Chk1 in Myc-expressing cancer cells Clin Cancer Res 17 2011 7067 7079
37. N. Suwaki, K. Klare, and M. Tarsounas RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis Semin Cell Dev Biol 22 2011 898 905
38. Y. Hayashita, H. Osada, Y. Tatematsu, H. Yamada, K. Yanagisawa, and S. Tomida et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation Cancer Res 65 2005 9628 9632
39. K.A. O'Donnell, E.A. Wentzel, K.I. Zeller, C.V. Dang, and J.T. Mendell C-Myc-regulated microRNAs modulate E2F1 expression Nature 435 2005 839 843
40. T. Oskarsson, and A. Trumpp The Myc trilogy: lord of RNA polymerases Nat Cell Biol 7 2005 215 217
41. E. Riu, T. Ferre, A. Mas, A. Hidalgo, S. Franckhauser, and F. Bosch Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism Biochem J 368 2002 931 937